Highlights
Baxalta Pharmaceutical Company receives positive EMA decision on paediatric investigation plan (PIP) for leniolisib in Europe
Lees meer
Baxalta Pharmaceutical Company and Sanofi renew strategic manufacturing partnership agreement
Lees meer
Baxalta Pharmaceutical Company reports financial results for the first nine months of 2021
Lees meer